Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Neurobiology

• Publication date

  2007-10-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12035-007-8007-7PMID 17952647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

  2007cited by this paper
• The antinociceptive effects of intraplantar injections of 2‐arachidonoyl glycerol are mediated by cannabinoid CB2 receptors

  2007cited by this paper
• Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes

  2006cited by this paper
• CB2 cannabinoid receptor mediation of antinociception

  2006cited by this paper
• The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.

  2006cited by this paper
• Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

  2006cited by this paper
• Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats

  2006cited by this paper
• CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms

  2006cited by this paper
• Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.

  2006cited by this paper
• Cannabinoid receptors as therapeutic targets.

  2006cited by this paper
• Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.

  2006cited by this paper
• Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

  2005cited by this paper
• Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

  2005cited by this paper
• Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

  2005cited by this paper
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper
• A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.

  2005cited by this paper
• Immune and glial cell factors as pain mediators and modulators.

  2005cited by this paper
• Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.

  2005cited by this paper
• Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

  2005cited by this paper
• Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli

  2005cited by this paper
• Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain.

  2005cited by this paper
• Central Proinflammatory Cytokines and Pain Enhancement

  2005cited by this paper
• Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures

  2005cited by this paper
• Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin.

  2005cited by this paper
• Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat

  2005cited by this paper
• BMC Neurology BioMed Central

  2004cited by this paper
• Cannabinoid signaling in glial cells

  2004cited by this paper
• Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.

  2004cited by this paper
• Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

  2004cited by this paper
• Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain.

  2004cited by this paper
• Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

  2004cited by this paper
• Evidence that CB‐1 and CB‐2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat

  2004cited by this paper
• Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies

  2004cited by this paper
• Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

  2003cited by this paper
• Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

  2003cited by this paper
• Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

  2003influential reference
• Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors

  2003cited by this paper
• Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.

  2003cited by this paper
• Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide

  2003cited by this paper
• Inhibition of guinea‐pig and human sensory nerve activity and the cough reflex in guinea‐pigs by cannabinoid (CB2) receptor activation

  2003cited by this paper
• The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.

  2003cited by this paper
• Analgesic Effects of Cannabinoids: Sites and Mechanisms of Action

  2003cited by this paper
• Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

  2003cited by this paper
• CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

  2003cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

  2003cited by this paper
• Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

  2002cited by this paper
• Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation.

  2002cited by this paper
• Attenuation of nerve growth factor‐induced visceral hyperalgesia via cannabinoid CB1 and CB2‐like receptors

  2002cited by this paper
• Cannabinoid analgesia.

  2002cited by this paper
• Endocannabinoids and related fatty acid derivatives in pain modulation.

  2002cited by this paper
• Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.

  2002cited by this paper
• Administration of Endocannabinoids Prevents a Referred Hyperalgesia Associated with Inflammation of the Urinary Bladder

  2001cited by this paper
• CB2 cannabinoid receptor‐mediated peripheral antinociception

  2001cited by this paper
• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

  2001cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception.

  2001cited by this paper
• Cannabinoids inhibit LPS‐inducible cytokine mRNA expression in rat microglial cells

  2000cited by this paper
• Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.

  2000cited by this paper
• Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C‐terminal tail of CB1

  2000cited by this paper
• Interleukin‐1β Induces Substance P Release from Primary Afferent Neurons Through the Cyclooxygenase‐2 System

  1999cited by this paper
• Cannabinoid receptors undergo axonal flow in sensory nerves.

  1999cited by this paper
• 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.

  1999cited by this paper
• HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

  1999cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

  1998influential reference
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• The anti‐hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

  1998cited by this paper
• Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals.

  1997cited by this paper
• N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.

  1996cited by this paper
• Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

  1996cited by this paper
• Characterization of a rat model of incisional pain

  1996cited by this paper
• Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.

  1995cited by this paper
• Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein.

  1995cited by this paper
• Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.

  1995cited by this paper
• Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

  1995cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Two forms of inhibition of spinothalamic tract neurons produced by stimulation of the periaqueductal gray and the cerebral cortex.

  1991cited by this paper
• Molecular cloning of a human cannabinoid receptor which is also expressed in testis.

  1991cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

  1964cited by this paper
• Identification functional characterization of brainstem cannabinoid CB2 receptors.

  year unknowncited by this paper

• Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action

  2025cites this paper
• The Role of Endocannabinoids in Physiological Processes and Disease Pathology: A Comprehensive Review

  2025influential citation
• Medical marijuana in the treatment of cancer-associated symptoms

  2024cites this paper
• Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways

  2024influential citation
• Exploring orphan GPCRs in neurodegenerative diseases

  2024cites this paper
• Stretchable hierarchical metal wire networks for neuromorphic emulation of nociception and anti-nociception.

  2024cites this paper
• Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation.

  2023cites this paper
• Cannabinoids and Pain: Mechanisms of Action

  2021cites this paper
• Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

  2021cites this paper
• Genetic Variation and Sex Mediate Differential Responses to ∆-9-tetrahydrocannabinol among Inbred Mice

  2020cites this paper
• Lavandula angustifolia essential oil inhalation reduces mechanical hyperalgesia in a model of inflammatory and neuropathic pain: The involvement of opioid and cannabinoid receptors.

  2020cites this paper
• Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease

  2020cites this paper
• Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians

  2020cites this paper
• Cannabis Sativa Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis

  2019cites this paper
• Using Cannabis to Treat Cancer-Related Pain.

  2019cites this paper
• The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System

  2019cites this paper
• Cannabinoide in der Schmerzmedizin

  2018cites this paper
• Gainfully employing descending controls in acute and chronic pain management.

  2018cites this paper
• Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

  2018cites this paper
• Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials

  2018cites this paper
• Endocannabinoid System and Migraine Pain: An Update

  2018cites this paper
• Brain cannabinoid receptor 2: expression, function and modulation

  2017cites this paper
• Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1

  2017influential citation
• Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE)

  2017cites this paper
• Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor

  2017cites this paper
• Cannabinoids and Their Effects on Painful Neuropathy

  2017cites this paper
• Análogos de cannabinoides en el tratamiento del dolor

  2016cites this paper
• Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

  2016cites this paper
• CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

  2016cites this paper
• The endocannabinoid system and neuropathic pain

  2016cites this paper
• Chapter 3 – Analgesics

  2016cites this paper
• The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice

  2016cites this paper
• Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.

  2015cites this paper
• Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission

  2015cites this paper
• Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain

  2015cites this paper
• Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor.

  2015cites this paper
• Chronic cannabinoid CB 2 activation reverses paclitaxel neuropathy without tolerance or CB 1 -dependent withdrawal

  2015cites this paper
• Vulfsons The Endocannabinoid System , Cannabinoids , and Pain

  2015cites this paper
• Hydroxyalkylation with Cyclic Sulfates: Synthesis of Carbazole Derived CB2 Ligands with Increased Polarity

  2014cites this paper
• Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol.

  2014cites this paper
• Peripheral gating of pain signals by endogenous analgesic lipids

  2014cites this paper
• JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.

  2014cites this paper
• Endocannabinoids and neuropathic pain: focus on neuron–glia and endocannabinoid–neurotrophin interactions

  2014cites this paper
• Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia.

  2014cites this paper
• Cannabinoids for Neuropathic Pain

  2014cites this paper
• Peripheral gating of pain signals by endogenous lipid mediators

  2014cites this paper
• Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB2 receptors

  2013cites this paper
• Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin‐induced pain and hyperalgesia

  2013cites this paper
• The Endocannabinoid System, Cannabinoids, and Pain

  2013cites this paper
• Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies.

  2013cites this paper
• Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal

  2013cites this paper
• Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists.

  2013cites this paper
• Nabilone in in fl ammatory pain : to

  2012cites this paper
• The Effects of Peptide and Lipid Endocannabinoids on Arthritic Pain at the Spinal Level

  2012cites this paper
• A synthetic approach for (S)-(3-benzyl-3-methyl-2,3-dihydro-benzofuran-6-yl)-piperidin-1-yl-methanone, a selective CB2 receptor agonist

  2012cites this paper
• Nabilone in inflammatory pain: to be or not to be

  2012cites this paper
• The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy

  2012cites this paper
• Lack of effect of central nervous system‐active doses of nabilone on capsaicin‐induced pain and hyperalgesia

  2012cites this paper
• Système endocannabinoïde et physiopathologie de l’obésité : rôle des CB1R (périphériques) du tissu adipeux et du foie

  2011cites this paper
• A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction

  2011cites this paper
• Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol

  2011cites this paper
• Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example

  2011cites this paper
• Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.

  2011cites this paper
• Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats

  2011cites this paper
• Structure-activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain.

  2011cites this paper
• Dérivés de pyridazine utiles en tant qu'agonistes du cannabinoïde-2

  2011cites this paper
• Composés spécifiques de type diarylhydantoïne et diarylthiohydantoïne

  2010cites this paper
• Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers

  2010cites this paper
• Peripheral antinociceptive effect of 2‐arachidonoyl‐glycerol and its interaction with endomorphin‐1 in arthritic rat ankle joints

  2010cites this paper
• Opioids and cannabinoids interactions: involvement in pain management.

  2010cites this paper
• 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice.

  2010cites this paper
• Role of Endocannabinoids in Neuron-Glial Crosstalk

  2010cites this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain

  2010cites this paper
• Cellular mechanisms underlying the interaction between cannabinoid and opioid system.

  2010cites this paper
• OPIOID-CANNABINOID CODRUGS WITH ENHANCED ANALGESIC AND PHARMACOKINETIC PROFILE

  2010cites this paper
• Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

  2010cites this paper
• Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization

  2010cites this paper
• Impact du système endocannabinoïdien sur la physiologie de l'obésité : effets de l'antagonisme des récepteurs CB1 sur le métabolisme glucido-lipidique de la souris obèse

  2010cites this paper
• Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory pain.

  2010cites this paper
• Brain CB2 Receptors: Implications for Neuropsychiatric Disorders

  2010cites this paper
• Peripheral antinociceptive effect of 2-arachidonoyl-glycerol and its interaction with endomorphin-1 in arthritic rat ankle joints.

  2010cites this paper
• Cannabinoid and opioid system in the mechanisms and control of pain

  2009cites this paper
• Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective

  2009influential citation
• Cannabinoid type 2 receptor as a target for chronic - pain.

  2009cites this paper
• [Cannabinoid and opioid system in the mechanisms and control of pain].

  2009cites this paper
• Sistemas cannabinoide y opioide en los mecanismos y el control del dolor

  2009cites this paper
• Cannabinoid Receptor Mediated Analgesia: Novel Targets for Chronic Pain States

  2009cites this paper
• Mode of action of cannabinoids on nociceptive nerve endings

  2009cites this paper
• Dynamic regulation of the endocannabinoid system: implications for analgesia

  2009cites this paper
• Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain

  2009cites this paper
• Targeting the cannabinoid system to produce analgesia.

  2009cites this paper
• 2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.

  2009cites this paper
• Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.

  2009cites this paper
• The endocannabinoid system and pain.

  2009cites this paper
• EFFECTS OF CANNABIDIOL AND CANNABIS EXTRACTS IN MODELS OF CONVULSION AND EXCITOTOXICITY

  2008cites this paper
• Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non‐cannabinoid receptor‐mediated mechanisms

  2008cites this paper
• Modulation of the anti‐nociceptive effects of 2‐arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model

  2008influential citation
• Effects of cannabidiol and cannabis extracts in models of convulsion and excitotoxicity

  2008cites this paper
• Polythérapie pour réduire les effets secondaires à l'aide de ligands des récepteurs cannabinoïdes

  2008cites this paper
• Endocannabinoid‐mediated enhancement of fear‐conditioned analgesia in rats: Opioid receptor dependency and molecular correlates

  2008cites this paper